https://immunwork.dnsalias.org/2018/10/12/%e3%80%90reported-by-taiwan-science-moothly%e3%80%91essence-of-new-drug-invention-breakthrough-existing-techniques-to-create-greater-medical-value/2026-06-02T17:15:29+08:00https://immunwork.dnsalias.org/2019/07/18/immunwork-won-the-2019-outstanding-biotechnology-industry-award-potential-benchmark-award/2026-06-03T10:37:09+08:00https://immunwork.dnsalias.org/2019/09/17/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91immunwork-opening-multiple-products-under-simultaneous-development/2026-06-03T10:39:22+08:00https://immunwork.dnsalias.org/2020/05/07/%e3%80%90reported-by-taiwan-commonwealth-magazine%e3%80%91the-name-of-novel-drug-which-get-the-largest-authorization-comes-from-the-birthday-of-the-father-of-antibodies-in-taiwan/2026-06-03T10:40:41+08:00https://immunwork.dnsalias.org/2021/04/06/te-8105-drug-development-was-selected-as-a-significant-case-of-the-center-for-drug-evaluation-cde-taiwan/2026-06-03T10:41:41+08:00https://immunwork.dnsalias.org/2022/03/08/immunwork-completed-the-a-run-foundraising-of-670-million-six-novel-drugs-have-been-verified/2026-06-03T10:42:49+08:00https://immunwork.dnsalias.org/2022/03/10/%e3%80%90reported-by-taiwan-commercial-times%e3%80%91can-dr-tse-wen-chang-the-leader-of-biotechnology-stocks-set-another-record/2026-06-03T10:44:30+08:00https://immunwork.dnsalias.org/2022/03/17/%e3%80%90reported-by-taiwan-money-weekly%e3%80%91t-e-drug-platform-of-immunwork-create-new-generation-of-novel-drugs/2026-06-03T14:14:41+08:00https://immunwork.dnsalias.org/2022/04/29/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91immunwork-won-the-first-prize-of-investment-matchmaking-competition/2026-06-03T10:46:13+08:00https://immunwork.dnsalias.org/2022/06/16/%e3%80%90taiwan-global-bio-monthly-cover-story%e3%80%91dr-tse-wen-chang-founded-immunwork-completed-foundraising-of-670-million-potentially-get-licensed-business-opportunities/2026-06-03T10:47:40+08:00https://immunwork.dnsalias.org/2022/07/14/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91precision-therapy-industry-development-trends-forum-immunwork-presents-the-latest-progress/2026-06-03T10:48:59+08:00https://immunwork.dnsalias.org/2022/11/01/recognized-as-a-biotechnology-and-pharmaceutical-company-by-the-ministry-of-economic-affairs-r-o-c/2026-06-03T10:50:02+08:00https://immunwork.dnsalias.org/2022/11/15/invited-lectures-on-november-15th-2022-antibody-therapeutic-conference-extended-application-of-antibody/2026-06-03T10:51:38+08:00https://immunwork.dnsalias.org/2023/01/01/%e3%80%90reported-by-economic-daily%e3%80%91immunworks-novel-drugs-challenge-incurable-diseases/2026-06-03T10:59:41+08:00https://immunwork.dnsalias.org/2023/01/05/immunwork-to-present-at-biotech-showcase-2023-updates-in-proprietary-adc-arc-technology-platforms-and-fundraising-plan/2026-06-03T11:00:45+08:00https://immunwork.dnsalias.org/2023/02/18/immunwork-to-present-at-the-2nd-next-generation-conjugates-summit-in-boston/2026-06-03T11:01:56+08:00https://immunwork.dnsalias.org/2023/06/01/bio-2023-international-convention-in-boston/2026-06-03T11:03:01+08:00https://immunwork.dnsalias.org/2023/06/16/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91immunwork-link-future-to-t-e-meds-promoting-adc-arc-platforms-development/2026-06-03T11:04:43+08:00https://immunwork.dnsalias.org/2023/07/06/immunwork-will-present-at-bio-asia-taiwan-conference/2026-06-03T11:06:46+08:00https://immunwork.dnsalias.org/2023/07/19/immunworks-latest-research-result-is-published-in-j-med-chem/2026-06-03T11:07:51+08:00https://immunwork.dnsalias.org/2023/07/21/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91the-president-dr-tse-wen-chang-presents-the-immunworks-latest-progress-in-the-40th-anniversary-activities-of-development-cent/2026-06-03T11:09:42+08:00https://immunwork.dnsalias.org/2023/09/15/t-e-meds-provides-complementary-technologies-with-cho-pharma-to-form-a-robust-adc-development-platform/2026-06-03T11:10:52+08:00https://immunwork.dnsalias.org/2023/09/25/immunworks-affiliated-company-t-e-meds-has-received-an-invitation-to-present-the-latest-adc-technology-platform-at-the-world-adc-san-diago-conference/2026-06-03T11:12:41+08:00https://immunwork.dnsalias.org/2023/10/11/join-our-presentation-at-the-world-adc-san-diego-2023/2026-06-03T11:14:36+08:00https://immunwork.dnsalias.org/2024/01/12/immunwork-2024-investor-meeting-results-presentation/2026-06-03T11:16:18+08:00https://immunwork.dnsalias.org/2024/01/15/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91the-president-dr-tse-wen-chang-shares-the-experiences-and-expectation-in-the-2024-biotechnology-trends-and-opportunities-foru/2026-06-03T11:17:49+08:00https://immunwork.dnsalias.org/2024/02/17/fda-approves-xolair-as-first-and-only-medicine-for-children-and-adults-with-one-or-more-food-allergies/2026-06-03T11:19:48+08:00https://immunwork.dnsalias.org/2024/02/20/join-our-presentation-at-the-prestigious-j-p-morgan-healthcare-conference/2026-06-03T11:23:52+08:00https://immunwork.dnsalias.org/2024/03/14/our-latest-research-result-is-published-in-advanced-science/2026-06-03T11:25:05+08:00https://immunwork.dnsalias.org/2024/06/24/the-2024-tang-prize-is-awarded-to-three-scientists-for-the-development-of-glp-1/2026-06-03T11:26:10+08:00https://immunwork.dnsalias.org/2024/06/25/join-our-presentation-at-the-world-adc-asia-2024-conference/2026-06-03T11:28:05+08:00https://immunwork.dnsalias.org/2024/07/30/two-ultra-long-acting-drugs-receive-promising-news-phase-1-clinical-trials-are-expected-to-be-completed-next-year/2026-06-03T11:30:31+08:00https://immunwork.dnsalias.org/2024/08/27/join-our-presentation-at-the-access-china-partnering-forum/2026-06-03T11:33:18+08:00https://immunwork.dnsalias.org/2024/11/22/we-will-be-participating-in-the-8th-taiwan-healthcare-expo-taiwan-welcome-to-visit-us/2026-06-03T11:34:43+08:00https://immunwork.dnsalias.org/2024/12/26/immunwork-won-the-21st-national-innovation-award-enterprise-innovation-award/2026-06-03T11:36:38+08:00https://immunwork.dnsalias.org/2025/01/06/t-e-meds-and-orient-europharma-forge-licensing-agreement-for-te-1146/2026-06-03T11:37:46+08:00https://immunwork.dnsalias.org/2025/01/15/immunwork-2025-investor-meeting-results-presentation/2026-06-03T11:38:35+08:00https://immunwork.dnsalias.org/2025/03/06/our-latest-research-result-is-published-in-j-med-chem/2026-06-03T11:39:51+08:00https://immunwork.dnsalias.org/2025/03/27/%e3%80%90reported-by-taiwan-global-bio-monthly%e3%80%91the-president-dr-tse-wen-chang-was-invited-as-a-keynote-speaker-at-biologics-world-taiwan-2025/2026-06-03T11:41:15+08:00https://immunwork.dnsalias.org/2025/06/24/t-e-meds-and-asymchem-join-forces-to-drive-innovation-in-drug-conjugates-and-explore-the-future-of-targeted-therapeutics/2026-06-03T11:42:41+08:00https://immunwork.dnsalias.org/2025/07/01/immunwork-announces-positive-phase-i-top-line-data-for-te-8214-a-long-acting-octreotide-demonstrating-favorable-safety-tolerability-and-potent-igf-1-suppression/2026-06-03T11:44:25+08:00https://immunwork.dnsalias.org/2025/11/07/t-e-meds-shortlisted-for-world-adc-awards-best-new-drug-developer/2026-06-03T11:47:31+08:00https://immunwork.dnsalias.org/2025/11/14/in-depth-interview-with-chairman-tse-wen-chang-leading-t-e-meds-in-advancing-adc-technology/2026-06-03T11:48:45+08:00https://immunwork.dnsalias.org/2025/12/08/immunwork-announces-positive-phase-1-2a-results-for-te-8105-a-long-acting-glp-1-ra-demonstrating-favorable-safety-tolerability-and-weight-loss-potential/2026-06-03T11:50:24+08:00https://immunwork.dnsalias.org/2025/12/26/immunwork-spotlight-te-8214-a-long-acting-drug-revolution-from-maltose-to-aqueous-solution/2026-06-03T11:52:11+08:00https://immunwork.dnsalias.org/2026/01/21/an-interview-with-chairman-tse-wen-chang-founder-of-immunwork-and-t-e-meds-a-journey-through-science-and-entrepreneurship/2026-06-03T11:53:44+08:00https://immunwork.dnsalias.org/2026/01/29/t-e-pharma-hosts-annual-year-end-gala-as-five-drug-candidates-reach-key-development-milestones/2026-06-03T11:55:02+08:00https://immunwork.dnsalias.org/2026/03/03/te-6168-drug-development-was-selected-as-a-significant-case-of-the-center-for-drug-evaluation-cde-taiwan/2026-06-03T11:56:00+08:00https://immunwork.dnsalias.org/2026/03/18/join-our-presentation-at-the-biologics-world-taiwan-2026/2026-06-03T11:58:49+08:00https://immunwork.dnsalias.org/2026/03/19/our-latest-research-published-in-international-journal-of-pharmaceutics/2026-06-03T12:00:40+08:00https://immunwork.dnsalias.org/2026/04/15/t-e-pharma-launches-pre-ipo-capital-raise-pursuing-a-dual-engine-strategy-in-metabolic-and-oncology-therapeutics-targeting-tpex-emerging-stock-board-listing-in-q4-2026/2026-06-03T14:06:14+08:00https://immunwork.dnsalias.org/2026/05/06/our-core-technology-platform-published-in-the-journal-of-the-chinese-chemical-society/2026-06-03T14:09:58+08:00